Periodontal Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Non-surgical Treatment, Surgical Devices ), By End User, By Region & Competition, 2021-2031F

The Global Periodontal Market is projected to expand from a valuation of USD 2.12 Billion in 2025 to USD 3.19 Billion by 2031, reflecting a CAGR of 7.05%. This industry segment encompasses a specialized array of dental therapeutics and devices aimed at preventing, diagnosing, and treating gum diseases such as gingivitis and periodontitis, including local and systemic antimicrobials, surgical instrumentation, and regenerative bone grafts. The market's growth is fundamentally anchored by an aging global population, which is inherently more prone to periodontal degeneration, alongside rising clinical acknowledgment of the bi-directional link between oral health and systemic issues like diabetes. These drivers generate a lasting demand for effective medical management solutions, distinguishing them from purely cosmetic dental trends.

Conversely, the market encounters significant hurdles due to the widespread insufficiency of reimbursement policies, which result in high out-of-pocket expenses and reduce patient adherence in many areas. This financial obstacle restricts access to advanced therapies and necessary long-term maintenance protocols. Data from the FDI World Dental Federation in 2025 estimated that severe periodontal diseases affected over one billion cases globally, highlighting a profound disparity between the substantial disease burden and the economic accessibility of required treatments.

Market Driver

The escalating global prevalence of periodontal diseases serves as the primary engine for market expansion, establishing a fundamental requirement for continuous therapeutic intervention. As gum conditions advance from gingivitis to severe periodontitis, the clinical workload necessitates a higher volume of diagnostic screenings, scaling procedures, and pharmacological treatments. This volume-based demand is particularly intense in developing nations where oral hygiene education is limited, yet it remains a persistent issue in developed countries due to aging demographics. According to a July 2025 study by the National Institutes of Health on the global burden of periodontal diseases, estimates indicated approximately 89.6 million incident cases in a single year, underscoring the constant influx of new patients requiring care.

Additionally, growing awareness regarding the systemic connection between oral health and chronic diseases is transforming treatment protocols and patient referral networks. Clinicians are increasingly moving toward a holistic model where periodontal management is integrated into care plans for systemic conditions such as diabetes mellitus and cardiovascular disease, elevating it from elective hygiene to essential medical management. The European Federation of Periodontology reported in November 2024 that studies show diabetics face a threefold higher risk of severe gum disease compared to non-diabetics. This shift is supported by economic trends; the American Dental Association recorded a 3% increase in consumer dental spending in 2025, signaling a sustained financial commitment to oral healthcare.

Market Challenge

The widespread absence of adequate reimbursement policies acts as a major impediment to the Global Periodontal Market, creating a significant financial barrier for both patients and dental providers. Limited insurance coverage for periodontal procedures compels patients to shoulder high out-of-pocket costs, often resulting in the delay or refusal of essential treatments. This economic constraint directly dampens the demand for advanced dental therapeutics, surgical instrumentation, and expensive regenerative materials, as patients frequently choose cheaper or less invasive alternatives.

Furthermore, dental practices are discouraged from investing in premium periodontal technologies when compensation rates fail to cover operational costs, leading to market stagnation despite the rising clinical need. According to the American Dental Association, in 2025, approximately 58 percent of dental practitioners identified low insurance reimbursement rates and claim denials as a primary challenge hindering their ability to maintain practice viability and deliver optimal care. This financial disconnect effectively suppresses the commercial adoption of periodontal products and restricts the broader expansion of the sector.

Market Trends

The integration of Artificial Intelligence into predictive diagnostics is fundamentally reshaping the periodontal landscape by shifting clinical workflows from subjective assessment to objective, data-driven disease management. AI algorithms now automatically quantify bone level measurements and identify early-stage radiographic bone loss with a precision that exceeds traditional manual methods, thereby enhancing diagnostic accuracy and patient trust. This technological evolution directly benefits practice revenue cycles by validating treatment necessity to patients who often struggle to visualize asymptomatic gum disease, effectively bridging the communication gap. A July 2025 Forbes article citing an Overjet survey noted that 72% of patients would be more likely to accept a dentist's diagnosis and treatment plan if presented with AI-generated findings, highlighting the technology's critical role in converting proposed therapies into active cases.

Simultaneously, advancements in Regenerative Tissue Engineering and Biologics are redefining therapeutic possibilities by enabling the restoration of lost periodontal support structures rather than merely arresting disease progression. Clinicians are increasingly utilizing advanced biomaterials, such as growth-factor-enhanced bone grafts and barrier membranes, to facilitate true periodontal regeneration around compromised teeth and implants. This shift toward biological preservation is sustaining robust commercial performance for major industry players, driving demand for premium regenerative portfolios despite broader economic headwinds. For instance, the Straumann Group reported in February 2025 that their full-year revenue reached CHF 2.5 billion, a figure significantly bolstered by the continued adoption of their premium implant and biomaterial solutions in key global markets.

Key Market Players

• Medtronic PLC
• Straumann AG
• The 3M Company
• Bausch Health Companies Inc.
• Dentsply Sirona Group
• Pfizer Inc.
• Novartis AG
• Dentsply Sirona Inc.
• Danaher Corporation
• GC Corporation

Report Scope

In this report, the Global Periodontal Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Periodontal Market, By Therapy

• Non-surgical Treatment (Local Antibiotics, Systemic Antibiotics, Laser Treatment)
• Surgical Devices (Bone Implants, Bone Grafting)

Periodontal Market, By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Periodontal Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Periodontal Market.

Available Customizations:

Global Periodontal Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).